Altimmune Stock Drop Prompts Levi & Korsinsky Lawsuit

Levi & Korsinsky, LLP announced a class action lawsuit against Altimmune, Inc. (NASDAQ: ALT) following a significant stock price decline after the release of disappointing Phase 2b trial results for Pemvidutide. Investors who suffered losses between August 10, 2023, and June 25, 2025, are urged to contact the firm.



